A vital target for cancer therapy, mTOR activation occurs often in human tumours (Loewith et al., 2002; Guertin and Sabatini, 2007; Laplante and Sabatini, 2012; Saxton and Sabatini, 2017; Chen and Zhou, 2020). The gene discussed is MTOR; the disease is cancer.